Revolutionizing Skin Cancer Treatment: Reno Tahoe Dermatology Offers Nonsurgical Option

Innovative Nonsurgical Treatment for Skin Cancer in Nevada

In a groundbreaking development for skin cancer treatment in Nevada, Reno Tahoe Dermatology has introduced a nonsurgical option known as Image-Guided Superficial Radiation Therapy (Image-Guided SRT). This advanced treatment method focuses on addressing common skin cancers including basal and squamous cell carcinomas. Renowned for its high efficacy, this method has produced an impressive 99.3% cure rate in treated patients, while vastly improving their treatment experience.

SkinCure Oncology, the leading provider of this treatment, announced its collaboration with Reno Tahoe Dermatology, marking the first instance of such an offering in the state. This initiative was made public during a recent event featuring Dr. Billie Casse, one of the leading dermatologists at the clinic, along with notable local figures like Brandi Anderson, a Reno City Council member, and Molly Rose Lewis, Northern Nevada Community Development Manager for U.S. Senator Jacky Rosen.

Understanding Image-Guided SRT

Image-Guided SRT is a revolutionary approach that utilizes ultrasound imaging to precisely target the affected skin areas with low-dose x-rays. This targeted radiation effectively destroys cancer cells without the need for surgical intervention. Dr. Billie Casse highlighted that many Nevadans are expected to face skin cancer diagnoses this year, especially given the state’s high solar exposure levels.

“Living in the high desert significantly increases our exposure to UV radiation, which raises the risk for developing skin cancer,” said Dr. Casse. The introduction of the GentleCure™ Experience at Reno Tahoe Dermatology offers patients a gentle yet effective alternative to traditional surgical methods.

A Shift in Cancer Care

Kerwin Brandt, CEO of SkinCure Oncology, expressed his enthusiasm regarding this partnership. He emphasized the importance of giving patients more noninvasive options for treating nonmelanoma skin cancer. “Patients everywhere should have the choice of curing their nonmelanoma skin cancer without surgery,” he stated. This sentiment resonates well with the modern approach to medicine, where patient-centered care is paramount.

The benefits of Image-Guided SRT extend beyond its noninvasive nature. Patients often experience fewer side effects and a more streamlined treatment process, with studies showing results similar to those of surgical options but with the added comfort and convenience that patients seek.

National Reach and Backbone

The powerful outreach of SkinCure Oncology stretches across the United States, with nearly 500 physicians offering this innovative treatment nationwide. More than 100,000 patients have already availed themselves of the therapy, urging other medical practices to consider adopting this method as part of their service offerings.

Patients seeking options regarding nonmelanoma skin cancer can find extensive information at the GentleCure website and are encouraged to consult local practices, like Reno Tahoe Dermatology, to explore their options further.

In conclusion, the arrival of Image-Guided SRT in Nevada not only marks a significant advancement in the state’s dermatological services but also sets a precedent for enhancing cancer treatment care through innovative, nonsurgical approaches. The collaboration between Reno Tahoe Dermatology and SkinCure Oncology illustrates a dedication to improving patient outcomes by leveraging cutting-edge technology for safer and more effective cancer treatments.